Risk Factors for Falls and Neurocognitive Disorders CLSA
NCT ID: NCT03628768
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
12000 participants
OBSERVATIONAL
2019-07-23
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Factors for Falls and Fall-related Injuries Associated With Mild Neurocognitive Disorders
NCT03978650
The "Motoric Cognitive Risk" Syndrome in the Canadian Population
NCT03679026
Cognitive Prefrail and Frailty, and Motoric Cognitive Risk Syndrome: Prevalence and Association With Incident Adverse Health Events
NCT04275817
A Study of Why People With Early Memory Problems Fall or Almost Fall
NCT00434889
The Cognitive-Prefrail Syndrome and Its Association With Adverse Health Outcomes
NCT04240028
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy / Non fallers
Older cognitively healthy individuals Non fallers
Data collection
telephone interview questionnaire, in-home face-to-face interview, and data from the Collection Site
Healthy / Fallers without injuries
Older cognitively healthy individuals Fallers without injuries
Data collection
telephone interview questionnaire, in-home face-to-face interview, and data from the Collection Site
Healthy / Fallers with injuries
Older cognitively healthy individuals Fallers with injuries
Data collection
telephone interview questionnaire, in-home face-to-face interview, and data from the Collection Site
MCI / Non fallers
Older individuals with MCI and mild dementia Non fallers
Data collection
telephone interview questionnaire, in-home face-to-face interview, and data from the Collection Site
MCI / Fallers without injury
Older individuals with MCI and mild dementia Fallers without injuries
Data collection
telephone interview questionnaire, in-home face-to-face interview, and data from the Collection Site
MCI / Fallers with injury
Older individuals with MCI and mild dementia Fallers with injuries
Data collection
telephone interview questionnaire, in-home face-to-face interview, and data from the Collection Site
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
telephone interview questionnaire, in-home face-to-face interview, and data from the Collection Site
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants of the Comprehensive CLSA (i.e., individuals who participated in a 90-minute in-home face-to-face interview, and a visit to one of 11 Data Collection Sites across Canada where they took part in a range of physical assessments).
Exclusion Criteria
* Moderate to severe dementia (estimated from performance on cognitive tests and scores of the Activity of Daily Living (ADL) and Instrumental Activity Daily Living (IADL) scales. Abnormal scores will be defined as 2 Standard Deviations (SDs) or more below the normal score of all cognitive tests associated with scores of ADL (/6) \<3 and a score of IADL (/8) \<4)
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jewish General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olivier Beauchet
Professor of Geriatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier Beauchet, MD
Role: PRINCIPAL_INVESTIGATOR
Jewish General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jewish General Hospital
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-1453
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.